Author Archives: Kate Hutchinson

SBIR/STTR INTENSIVE WORKSHOP: NIH FOCUSED

Posted on by
Reply

The Center for Biotechnology will be hosting our annual SBIR/STTR NIH Focused Workshop on January 15-16, 2019.

Did you know that the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) SBIR/STTR programs award over $2.6 billion in high-risk, non-diluted R&D funding annually to qualified small businesses?

Learn more about SBIR/STTR funding at this 1.5-day session focused on the National Institutes of Health (NIH) which will cover program essentials and how to compete for funding. Training will include:
– Current information on the SBIR/STTR programs
– Strategies for targeting your proposal to address the mission and requirements of the NIH
– How to approach each section of your proposal
– Planning your commercialization strategy
– Writing to meet the reviewers’ expectations

Tuesday, January 15, 2019, 8:30am – 4:30pm
Wednesday, January 17, 2019, 8:30am –12:00pm

Location: Long Island High Technology Incubator
Main Conference Room
25 Health Sciences Drive
Stony Brook, NY 11794

Registration Fee: $60 | Space is Limited. Pre-registration is required.
REGISTER ONLINE

Free Course from NIH: Entrepreneurial Finance for Biomedical Innovators

Posted on by
Reply

The course is presented in a series of five sequential videos. The video modules and course details can be found here: https://www.nibib.nih.gov/entrepreneurial-finance-course

The National Institutes of Health (NIH) supports the development and commercialization of biomedical technologies through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. With the goal of bringing life-saving innovations to market, NIH SBIR/STTR funding provides early-stage seed capital to US-owned small businesses. While the commercialization of biomedical technologies can require a significant amount of both time and money, rigorous financial planning can help navigate and mitigate risks for small businesses and can enhance chances of success along the pathway to market. For biomedical innovators considering funding through the NIH SBIR/STTR programs (https://sbir.nih.gov), it is imperative to evaluate the use of federal grant funding within the context of a broader financial plan.

Course Objectives
The purpose of this course is to present biomedical entrepreneurs with a detailed framework for building a step-wise, validated financial plan. Moving beyond the short-term perspective of immediate financing needs to a comprehensive, long-term financial plan will increase the probability of success for your venture. The primary learning objectives for this course are as follows:

– Understand the importance of financial planning for your small business
– Gain perspective on SBIR/STTR funding within the broader context of your financial plan
– Learn practical approaches to developing a long-term financial plan
– Evaluate the various sources of funding
– Examine the use of comparables in validating your financial plan

 

Funding Opportunity: BARDA DRIVe EZ-BAA

Posted on by
Reply

As a BARDA DRIVe Accelerator, the Center for Biotechnology is pleased to announce that the simplified funding application process, called EZ BAA, is now open. Medical product developers, research teams, and companies offering disruptive solutions to health security threats are invited to submit abstracts beginning today using this simplified EZ BAA process.

Applications accepted through this streamlined process must offer transformative innovation, products and technologies to protect Americans from health security threats. This application process is a business friendly simple abstract.

In-scope priority areas include products and solutions to reduce illness and death from sepsis as part of DRIVe’s Solving Sepsis initiative; technologies and processes to identify infections and exposures to biological and other health threats, as outlined in the Early Notification to Act, Control, and Treat (ENACT) initiative; and tools and techniques to mitigate the damages and loss of life associated with catastrophic events.

Applying is simple:

  • Download the application form the DRIVe website.
  • Submit a technical abstract no longer than a 2,000 words
  • Include a cost proposal of an additional 2,000 words or less.
  • Proposed costs should not exceed $749,000.

What happens next:

  • Once submitted, DRIVe’s experts will review the application to ensure it is within scope and meets DRIVe criteria.
  • As the applicant, you’ll be notified of the review results within 30 days of your submission.

**The Center for Biotechnology is interested in working with potential applicants to help ensure the submission of a robust on-target proposal. If you are interested learning about how the Center for Biotechnology can help, please contact William Hanes: william.hanes@stonybrook.edu***

Learn more about the DRIVe EZ-BAA review criteria here.
Have questions? Looking more information? Contact DRIVeContracting@hhs.gov

Important SBIR/STTR Information Update from NIH

Posted on by
Reply

Update courtesy of BBC Entrepreneurial Training and Consulting

NIH is strongly encouraging small businesses to contact the appropriate Institute or Center early in their application planning to ensure their technology is a priority for the Institute/Center.

An updated SBIR/STTR Application Guide with additional instructions for SBIR Direct Phase II application preparation and submission will be posted by November 26, 2018. The following sections of each FOA are changed:

Part 2, Section I. Funding Opportunity Description The following has been added at the end of the section for each FOA:

PA-18-573 The following Components will not accept an SBIR Direct-to-Phase II submission:
– National Institute of Nursing Research (NINR)
– National Center for Complementary and Integrative Health (NCCIH)

PA-18-574 The following Components will not accept an SBIR Direct-to-Phase II submission:
– National Institute of Environmental Health Sciences (NIEHS )
– National Institute of Nursing Research (NINR)
– National Center for Complementary and Integrative Health (NCCIH)
– Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)
– Centers for Disease Control and Prevention (CDC) (All Components of CDC)
– U.S. Food and Drug Administration (FDA) (All Components of FDA)

Part 2, Section II. Award Information for both PA-18-573 and PA-18-574. Application types now allowed are:
– New (Phase I, Fast-Track)
– New (Direct Phase II)
– Renewal (Phase II)
– Resubmission (all phases)
– Phase IIB Competing Renewal (Phase IIB)
– Revision

The OER Glossary and the SF424 (R&R) SBIR/STTR Application Guide provide details on these application types.

Life Sciences Summit 2018: 10/24-10/25

Posted on by
Reply

The Center for Biotechnology’s annual Life Sciences Summit is an early-stage investor and business development conference for emerging companies and academic innovators. This year’s event will take place on October 24-25 at 10 on the Park at the Time Warner Center in New York City.

The objective of the meeting is to connect emerging companies with early-stage investors, business development professionals, and medical research foundations with the goal of advancing new innovations through clinical development. The robust, two-day program features:

– Emerging Company Showcase
– Pitch Doctor Sessions
– Pipeline Café
– Business Workshops & Plenary Sessions
– Therapeutic Focused Panels
– Online & Onsite Partnering
– Strategic partners presentations

View the full 2018 program and register at lifesciencessummit.org.